The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1-blood pressure measurement, diagnosis and assessment of risk

被引：55

作者：

Padwal, Raj S. ^{[1
]}

Hemmelgarn, Brenda R. ^{[2
]}

Khan, Nadia A. ^{[3
]}

Grover, Steven ^{[4
]}

McKay, Donald W. ^{[5
]}

Wilson, Thomas ^{[6
]}

Penner, Brian ^{[7
]}

Burgess, Ellen ^{[2
]}

McAlister, Finlay A. ^{[1
]}

Bolli, Peter ^{[8
]}

Hill, Michael D. ^{[9
,10
,11
]}

Mahon, Jeff ^{[12
]}

Myers, Martin G. ^{[13
]}

Abbott, Carl ^{[14
]}

Schiffrin, Ernesto L. ^{[15
]}

Honos, George ^{[16
]}

Mann, Karen ^{[17
]}

Tremblay, Guy ^{[18
]}

Milot, Alain ^{[19
]}

Cloutier, Lyne ^{[20
]}

Chockalingam, Arun ^{[21
]}

Rabkin, Simon W. ^{[22
]}

Dawes, Martin ^{[23
]}

Touyz, Rhian M. ^{[24
]}

Bell, Chaim ^{[25
,26
,27
]}

Burns, Kevin D. ^{[28
]}

Ruzicka, Marcel ^{[28
]}

Campbell, Norman R. C. ^{[10
,11
,29
]}

Vallee, Michel ^{[30
]}

Prasad, Ramesh ^{[31
]}

Lebel, Marcel ^{[32
]}

Tobe, Sheldon W. ^{[33
]}

机构：

[1] Univ Alberta, Div Gen Internal Med, Edmonton, AB T6G 2M7, Canada

[2] Univ Calgary, Div Nephrol, Calgary, AB, Canada

[3] Univ British Columbia, Div Gen Internal Med, Vancouver, BC V5Z 1M9, Canada

[4] Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada

[5] Mem Univ Newfoundland, Fac Med, St John, NF, Canada

[6] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada

[7] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada

[8] Ambulatory Internal Med Teaching Clin, St Catharines, ON, Canada

[9] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada

[10] Univ Calgary, Dept Med, Calgary, AB, Canada

[11] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada

[12] Univ Western Ontario, Dept Med & Endocrinol, London, ON N6A 3K7, Canada

[13] Sunnybrook Hlth Sci Ctr, Div Cardiol, Toronto, ON M4N 3M5, Canada

[14] Victoria Gen Hosp, Div Endocrinol, Halifax, NS B3H 2Y9, Canada

[15] Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ, Canada

[16] Sir Mortimer B Davis Jewish Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada

[17] Dalhousie Univ, Div Med Educ, Halifax, NS, Canada

[18] Hop St Sacrement, Ctr Hosp Affilie Univ Quebec, Serv Cardiol, Quebec City, PQ, Canada

[19] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada

[20] Univ Quebec, Dept Nursing, Trois Rivieres, PQ GA9 5H7, Canada

[21] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada

[22] Univ British Columbia, Div Cardiol, Vancouver, BC V5Z 1M9, Canada

[23] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada

[24] Univ Ottawa, Ottawa Hlth Res Inst, Kidney Res Ctr, Ottawa, ON, Canada

[25] Univ Toronto, Dept Med, Toronto, ON, Canada

[26] Univ Toronto, Dept Hlth Policy Management & Evolut, Toronto, ON, Canada

[27] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada

[28] Univ Ottawa, Div Nephrol, Ottawa, ON, Canada

[29] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada

[30] Univ Montreal, Hop Maison Neuve Rosemont, Div Nephrol, Montreal, PQ, Canada

[31] Univ Toronto, Div Nephrol, Toronto, ON, Canada

[32] Univ Laval, Dept Med, Ctr Hosp Univ Quebec, Hotel Dieu, Quebec City, PQ, Canada

[33] Univ Toronto, Div Nephrol, Toronto, ON, Canada

来源：

CANADIAN JOURNAL OF CARDIOLOGY | 2009年 / 25卷 / 05期

关键词：

Blood pressure; Diagnosis; Guidelines; High blood pressure; Hypertension; Risk factors; RANDOMIZED CONTROLLED-TRIAL; CORONARY HEART-DISEASE; RENAL-ARTERY STENOSIS; BLOOD-PRESSURE; DIABETES-MELLITUS; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR-DISEASE; CARDIAC OUTCOMES; PREVENTION; METAANALYSIS;

D O I：

10.1016/S0828-282X(09)70491-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVE: TO provide updated, evidence-based recommendations for the diagnosis and assessment of adults with hypertension. OPTIONS AND OUTCOMES: The diagnosis of hypertension is dependent on appropriate blood pressure measurement, the timely assessment of serially elevated readings, the degree of blood pressure elevation, the Method of measurement (office, ambulatory, home) and associated comorbidities. The presence of cardiovascular risk factors and target organ damage should be ascertained to assess global cardiovascular risk and determine the urgency, intensity and type of treatment required. EVIDENCE: MEDLINE searches were conducted from November 2007 to October 2008 with the aid of a medical librarian. Reference lists were scanned, experts were contacted, and the personal files of authors and subgroup members were used to identify additional studies. Content and methodological experts assessed studies using prespecified, standardized evidence-based algorithms. Recommendations were based oil evidence from peer-reviewed full,text articles only. RECOMMENDATIONS: Recommendations for blood pressure measurement, criteria for hypertension diagnosis and follow-up, assessment of global cardiovascular risk, diagnostic testing, diagnosis Of renovascular and endocrine causes of hypertension home and ambulatory monitoring, bind the use of echocardiography in hypertensive individuals are outlined. Key messages include continued emphasis on the expedited, accurate diagnosis of hypertension, the importance of global risk assessment and the need for ongoing monitoring of hypertensive patients to identify incident type 2 diabetes. VALIDATION: All recommendations were graded according to strength of the evidence and voted on by the 57 members of the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. All recommendations were required to be supported by at least 70% of task force members. These guidelines will continue to be updated annually.

引用

页码：279 / 286

页数：8

共 38 条

[11] What role do patients wish to play in treatment decision making? [J].

Deber, RB ;

Kraetschmer, N ;

Irvine, J .

ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (13) :1414-1420

[12]

Elliott WJ, 2007, LANCET, V369, P1518

[13]

Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197

[14] Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus [J].

Gress, TW ;

Nieto, FJ ;

Shahar, E ;

Wofford, MR ;

Brancati, FL .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13) :905-912

[15] Gadolinium and nephrogenic systemic fibrosis [J].

Grobner, T. ;

Prischl, F. C. .

KIDNEY INTERNATIONAL, 2007, 72 (03) :260-264

[16] Estimating the benefits of modifying risk factors of cardiovascular disease -: A comparison of primary vs secondary prevention [J].

Grover, SA ;

Paquet, S ;

Levinton, C ;

Coupal, L ;

Zowall, H .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) :655-662

[17] The role of global risk assessment in hypertension therapy [J].

Grover, SA ;

Hemmelgarn, B ;

Joseph, L ;

Milot, A ;

Tremblay, G .

CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (07) :606-613

[18] Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: A Randomized controlled trial [J].

Grover, Steven A. ;

Lowensteyn, Ilka ;

Joseph, Lawrence ;

Kaouache, Mohammed ;

Marchand, Sylvie ;

Coupal, Louis ;

Boudreau, Ghislain .

ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (21) :2296-2303

[19] The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk [J].

Hemmelgarn, BR ;

McAlister, FA ;

Grover, S ;

Myers, MG ;

McKay, DW ;

Bolli, P ;

Abbott, C ;

Schiffrin, EL ;

Honos, G ;

Burgess, E ;

Mann, K ;

Wilson, T ;

Penner, B ;

Tremblay, G ;

Milot, A ;

Chockalingam, A ;

Touyz, RM ;

Tobe, SW .

CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (07) :573-581

[20]

Hernmelgarn BR, 2005, CAN J CARDIOL, V21, P645

← 1 2 3 4 →